The Lancet Neurology

Contents

The Lancet Neurology The Lancet Neurology is a peer-reviewed medical journal focused on clinical neurology, neurological research, and neuroscience policy. Launched in 2002, it forms part of a family of medical journals associated with London, Elsevier, and trends in biomedical publishing linked to institutions such as University College London, Harvard Medical School, and Johns Hopkins University. The journal addresses topics of interest to clinicians and researchers connected to organizations like the World Health Organization, National Institutes of Health, and European Commission.

History

The journal was established in 2002 amid expansions of specialist titles by publishers including Elsevier, contemporaneous with launches of journals affiliated with entities such as BMJ Group and Wiley-Blackwell. Its early editorial leadership included figures associated with University of Oxford, University of Cambridge, and Imperial College London. The Lancet Neurology developed alongside landmark initiatives and events such as the Human Genome Project, the establishment of the European Union's Framework Programmes, and policy debates involving the World Health Organization and the National Health Service. Over time the title intersected with major research networks like Alzheimer's Disease Neuroimaging Initiative, collaborations involving Massachusetts General Hospital, and multicenter trials coordinated by groups such as National Institutes of Health and Wellcome Trust.

The journal publishes original research, reviews, meta-analyses, and commentaries covering conditions such as Alzheimer's disease, Parkinson's disease, stroke, multiple sclerosis, and epilepsy. It addresses clinical trials connected to networks like ClinicalTrials.gov and therapeutic developments involving companies such as Pfizer, Roche, and Biogen. Content engages with basic science from laboratories at institutions like Cold Spring Harbor Laboratory, Max Planck Society, and Salk Institute for Biological Studies, and translational studies referencing technologies from CRISPR-Cas9, MRI, and PET scan modalities. The journal situates findings within global health contexts involving agencies like World Health Organization, Pan American Health Organization, and funders such as Bill & Melinda Gates Foundation and Wellcome Trust.

Editorial leadership has included editors and advisors drawn from Harvard Medical School, Stanford University School of Medicine, Mayo Clinic, University of Toronto, and Columbia University. The publisher, Elsevier, distributes the journal alongside sister titles connected to The Lancet (journal) family and operates within publishing ecosystems that include CrossRef, PubMed Central, and indexing services like Web of Science. Peer review involves reviewers with affiliations to institutions such as National Institutes of Health, Karolinska Institutet, and University of Melbourne. Production and ethical oversight reference standards from organizations like the International Committee of Medical Journal Editors and the Committee on Publication Ethics.

The journal's articles have influenced clinical guidelines from bodies such as the National Institute for Health and Care Excellence, American Heart Association, and European Stroke Organisation. High-profile publications have been cited in policy statements by the World Health Organization and deliberations within assemblies like the United Nations General Assembly. Academic reception is measured through citations in databases maintained by Clarivate, Scopus, and Google Scholar, and recognition has intersected with prizes awarded by institutions such as the Royal Society and Academy of Medical Sciences. The title has been discussed in media outlets including The New York Times, BBC News, and The Guardian when reporting breakthroughs in areas linked to Alzheimer's disease and stroke care.

Notable contributions include randomized trials and landmark reviews that shaped practice in management of ischemic stroke, disease-modifying therapies for multiple sclerosis, and diagnostic criteria updates for dementia. Influential pieces cited by guideline panels at National Institute for Health and Care Excellence and American Academy of Neurology have informed interventions evaluated in trials funded by National Institutes of Health and philanthropic bodies such as Wellcome Trust. The journal has published work from researchers at Massachusetts General Hospital, Mayo Clinic, University College London, Karolinska Institutet, and collaborations with consortia such as European Alzheimer's Disease Consortium.

The journal is indexed in major bibliographic databases including MEDLINE, PubMed, Embase, Scopus, and Web of Science. Abstracting services and citation indexes provided by organizations like Clarivate Analytics and aggregators such as EBSCO and ProQuest include its content. Library catalogs at institutions such as Harvard Library, British Library, and National Library of Medicine list the journal among core neurology and neuroscience resources.

Category:Neurology journals